HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $520,027 | +11.4% | 4,495 | -0.9% | 0.00% | – |
| Q2 2023 | $466,630 | -8.0% | 4,537 | -2.4% | 0.00% | – |
| Q1 2023 | $507,283 | -20.4% | 4,648 | -17.0% | 0.00% | – |
| Q4 2022 | $636,939 | +85.2% | 5,597 | +0.7% | 0.00% | – |
| Q3 2022 | $343,985 | -24.0% | 5,558 | -2.1% | 0.00% | – |
| Q2 2022 | $452,798 | -28.9% | 5,677 | -6.2% | 0.00% | – |
| Q1 2022 | $636,836 | +50.2% | 6,053 | +54.0% | 0.00% | – |
| Q4 2021 | $424,000 | -1.6% | 3,931 | 0.0% | 0.00% | – |
| Q3 2021 | $431,000 | +17.1% | 3,931 | 0.0% | 0.00% | – |
| Q2 2021 | $368,000 | +1.7% | 3,931 | 0.0% | 0.00% | – |
| Q1 2021 | $362,000 | +25.7% | 3,931 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | -5.6% | 3,931 | 0.0% | 0.00% | – |
| Q3 2020 | $305,000 | +40.6% | 3,931 | 0.0% | 0.00% | – |
| Q2 2020 | $217,000 | – | 3,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |